Jump to content

Template:Antimigraine preparations: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

1 November 2024

14 October 2024

20 May 2024

23 May 2023

22 March 2023

10 March 2023

4 June 2022

  • curprev 01:5401:54, 4 June 2022 Yellow whisper talk contribs m 2,523 bytes −16 Atogepant was reassigned correctly to migraine prophylactic group. In prev. edition I need to create another CGRP-R subgroup in Prophylactic, because previously all CGRP antagonists was assigned as Abortive drugs. undo
  • curprev 01:5001:50, 4 June 2022 Yellow whisper talk contribs 2,539 bytes +120 Atogepant is indicated for migrene prophylactic, not for abortive usage. Other -gepant as rimagepant or ubrogepant ocrrectly are in abortive group. But atogepant definitely is approved for migrene prevention. Source of information: https://www.prnewswire.com/news-releases/fda-approves-qulipta-atogepant-the-first-and-only-oral-cgrp-receptor-antagonist-specifically-developed-for-the-preventive-treatment-of-migraine-301387297.html undo

29 September 2021

13 April 2021

28 February 2020

25 February 2020

28 December 2019

15 November 2019

6 March 2019

9 April 2018

5 August 2017

5 December 2016

11 February 2016

2 April 2015

15 February 2015

1 January 2015

5 August 2013

7 May 2013

2 May 2013

15 October 2012

16 September 2012

7 July 2012

14 June 2012

17 May 2012

12 August 2011

10 August 2011

10 March 2011

13 January 2011

30 November 2010

14 November 2010

24 June 2010

2 June 2010

23 March 2010

20 March 2010

16 January 2010

18 December 2009

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)